The Revenge Of Obamacare Just Tanked Merck And Other Pharmaceutical Manufacturers

Shares of Merck & Co. Inc. (MRK) are currently down $0.58 or 1.55% to $36.92 a share as Obama unveils his latest healthcare initiative.

One damming factor of the President’s agenda is a $10B hike in additional fees on drugmakers.

Shares of Glaxo Smith Kline (GSK) are also falling, currently down $0.83 or 2.2% to $37.42 a share. AmerisourceBergen Corp. (ABC) is down $0.17 or 0.66% to $27.95 a share.

drug companies feb21

NOW WATCH: Money & Markets videos

Want to read a more in-depth view on the trends influencing Australian business and the global economy? BI / Research is designed to help executives and industry leaders understand the major challenges and opportunities for industry, technology, strategy and the economy in the future. Sign up for free at